Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of Multiple ...

With federal privacy enforcement increasingly limited, state regulators have stepped forward as consumer privacy enforcers. This year may have ...

Program advancing rapidly, ahead of schedule and under budget HIGHLIGHTS Reverse circulation (RC) upgrade drilling on high ...

Info-Tech Research Group has confirmed the next group of featured speakers for LIVE 2025 in Montreal, taking place November 25–26 at Fairmont The Queen Elizabeth. The global IT research and ...

Could computers ever learn more like humans do, without relying on artificial intelligence (AI) systems that must undergo extremely expensive ...